Global Primary Biliary Cholangitis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Primary Biliary Cholangitis Treatment Market Overview

• 1.1 Product Overview and Scope of Primary Biliary Cholangitis Treatment
• 1.2 Classification of Primary Biliary Cholangitis Treatment by Types
  • 1.2.1 Global Primary Biliary Cholangitis Treatment Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Primary Biliary Cholangitis Treatment Revenue Market Share by Types in 2018
  • 1.2.3 Ursodeoxycholic Acid (UDCA)
  • 1.2.4 Obeticholic Acid (Ocaliva)
• 1.3 Global Primary Biliary Cholangitis Treatment Market by Application
  • 1.3.1 Global Primary Biliary Cholangitis Treatment Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Others
• 1.4 Global Primary Biliary Cholangitis Treatment Market by Regions
  • 1.4.1 Global Primary Biliary Cholangitis Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Primary Biliary Cholangitis Treatment Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Primary Biliary Cholangitis Treatment Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Primary Biliary Cholangitis Treatment Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Primary Biliary Cholangitis Treatment Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Primary Biliary Cholangitis Treatment Status and Prospect (2014-2024)
• 1.5 Global Market Size of Primary Biliary Cholangitis Treatment (2014-2024)

2 Manufacturers Profiles

• 2.1 Novartis
  • 2.1.1 Business Overview
  • 2.1.2 Primary Biliary Cholangitis Treatment Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Novartis Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Bristol-Myers Squibb
  • 2.2.1 Business Overview
  • 2.2.2 Primary Biliary Cholangitis Treatment Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Bristol-Myers Squibb Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Pfizer
  • 2.3.1 Business Overview
  • 2.3.2 Primary Biliary Cholangitis Treatment Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Pfizer Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 GlaxoSmithKline
  • 2.4.1 Business Overview
  • 2.4.2 Primary Biliary Cholangitis Treatment Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 GlaxoSmithKline Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Teva Pharmaceutical
  • 2.5.1 Business Overview
  • 2.5.2 Primary Biliary Cholangitis Treatment Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Teva Pharmaceutical Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Retrophin
  • 2.6.1 Business Overview
  • 2.6.2 Primary Biliary Cholangitis Treatment Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Retrophin Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Lumena Pharmaceuticals
  • 2.7.1 Business Overview
  • 2.7.2 Primary Biliary Cholangitis Treatment Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Lumena Pharmaceuticals Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Intercept Pharmaceuticals
  • 2.8.1 Business Overview
  • 2.8.2 Primary Biliary Cholangitis Treatment Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Intercept Pharmaceuticals Primary Biliary Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Primary Biliary Cholangitis Treatment Market Competition, by Players

• 3.1 Global Primary Biliary Cholangitis Treatment Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Primary Biliary Cholangitis Treatment Players Market Share
  • 3.2.2 Top 10 Primary Biliary Cholangitis Treatment Players Market Share
• 3.3 Market Competition Trend

4 Global Primary Biliary Cholangitis Treatment Market Size by Regions

• 4.1 Global Primary Biliary Cholangitis Treatment Revenue and Market Share by Regions
• 4.2 North America Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 4.3 Europe Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 4.5 South America Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)

5 North America Primary Biliary Cholangitis Treatment Revenue by Countries

• 5.1 North America Primary Biliary Cholangitis Treatment Revenue by Countries (2014-2019)
• 5.2 USA Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 5.3 Canada Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)

6 Europe Primary Biliary Cholangitis Treatment Revenue by Countries

• 6.1 Europe Primary Biliary Cholangitis Treatment Revenue by Countries (2014-2019)
• 6.2 Germany Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 6.3 UK Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 6.4 France Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 6.5 Russia Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 6.6 Italy Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Primary Biliary Cholangitis Treatment Revenue by Countries

• 7.1 Asia-Pacific Primary Biliary Cholangitis Treatment Revenue by Countries (2014-2019)
• 7.2 China Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 7.3 Japan Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 7.4 Korea Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 7.5 India Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)

8 South America Primary Biliary Cholangitis Treatment Revenue by Countries

• 8.1 South America Primary Biliary Cholangitis Treatment Revenue by Countries (2014-2019)
• 8.2 Brazil Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Primary Biliary Cholangitis Treatment by Countries

• 9.1 Middle East and Africa Primary Biliary Cholangitis Treatment Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 9.3 UAE Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Primary Biliary Cholangitis Treatment Revenue and Growth Rate (2014-2019)

10 Global Primary Biliary Cholangitis Treatment Market Segment by Type

• 10.1 Global Primary Biliary Cholangitis Treatment Revenue and Market Share by Type (2014-2019)
• 10.2 Global Primary Biliary Cholangitis Treatment Market Forecast by Type (2019-2024)
• 10.3 Ursodeoxycholic Acid (UDCA) Revenue Growth Rate (2014-2024)
• 10.4 Obeticholic Acid (Ocaliva) Revenue Growth Rate (2014-2024)

11 Global Primary Biliary Cholangitis Treatment Market Segment by Application

• 11.1 Global Primary Biliary Cholangitis Treatment Revenue Market Share by Application (2014-2019)
• 11.2 Primary Biliary Cholangitis Treatment Market Forecast by Application (2019-2024)
• 11.3 Hospitals Revenue Growth (2014-2019)
• 11.4 Clinics Revenue Growth (2014-2019)
• 11.5 Others Revenue Growth (2014-2019)

12 Global Primary Biliary Cholangitis Treatment Market Size Forecast (2019-2024)

• 12.1 Global Primary Biliary Cholangitis Treatment Market Size Forecast (2019-2024)
• 12.2 Global Primary Biliary Cholangitis Treatment Market Forecast by Regions (2019-2024)
• 12.3 North America Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
• 12.4 Europe Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
• 12.6 South America Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Primary Biliary Cholangitis Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology